Acta Pharmaceutica (Jun 2016)

Effect of rutin from tartary buckwheat sprout on serum glucose-lowering in animal model of type 2 diabetes

  • Lee Dong-Gi,
  • Jang Ik Soon,
  • Yang Kyeong Eun,
  • Yoon So-Jung,
  • Baek Sujeong,
  • Lee Joo Yong,
  • Suzuki Tatsuro,
  • Chung Keun-Yook,
  • Woo Sun-Hee,
  • Choi Jong-Soon

DOI
https://doi.org/10.1515/acph-2016-0021
Journal volume & issue
Vol. 66, no. 2
pp. 297 – 302

Abstract

Read online

This study investigates the anti-diabetic effects of rutin from tartary buckwheat sprout in type 2 diabetes mouse model. The rutin content in tartary buckwheat sprout (TBS) is five times higher than that found in common buckwheat sprout (CBS) as evident from high-performance liquid chromatography analysis. Administration of either rutin or TBS ethanolic extract to diabetes mice decreased the serum glucose level significantly. Rutin down-regulated the expression levels of protein-tyrosine phosphatase 1B; it is negative regulator of insulin pathway, both transcriptionally and translationally in myocyte C2C12 in a dose-dependent manner. In conclusion, rutin can play a critical role in down-regulation of serum glucose level in type 2 diabetes.

Keywords